product liability

Lawsuits and costs from products that cause harm, fail or need recalls.

Exposure · 10 companies

Show
8-K events
Match any selected event
8-K event types
More events

Only filters 8-Ks. Other selected forms stay visible.

  • ABT Abbott Laboratories

    Exposed“In Q3 Abbott recorded an approximately $670M charge for agreements resolving the Gill case and NEC claims brought on behalf of approximately 2,000 additional infants.”

    Latest 8-KExecutive pay ·

    Change-in-control agreements extended through Dec. 31, 2028 for named executives except CEO Robert B. Ford, whose agreement expires Dec. 31, 2026.

  • CMI Cummins

    Exposed“No recall had been initiated, and required modifications and costs remained undetermined, with potential material effects on results or cash flows.”

    Latest 10-QQ3 FY2026PositiveRestructuringImpairment / charge ·

    Data-center demand and stronger truck sales lift margins as Accelera narrows zero-emissions investments.

    • Revenue$9.4BYoY +13.5%
    • Net income$1.1BYoY +112.7%
  • CRWD CrowdStrike

    Exposed“The incident has led to securities, derivative, and consumer class-action lawsuits, as well as government and third-party inquiries.”

    Latest 10-QQ2 FY2027Mixed ·

    New customers and additional Falcon modules strengthened subscription growth, while outage-related concessions still constrain upsells.

    • Revenue$1.5BYoY +25.8%
    • Net income$5.3Mvs −$70.2M year ago
  • GM General Motors

    Exposed“Regulatory, emissions, product-liability, tariff and supply-chain uncertainties remain significant.”

    Latest 8-KLeadership change ·

    Chief Accounting Officer Christopher T. Hatto plans to retire April 1, 2027, remaining principal accounting officer through that date.

  • JNJ Johnson & Johnson

    Exposed“J&J faces numerous talc-related lawsuits, primarily involving JOHNSON’S Baby Powder, and notes potential joint-and-several liability.”

    Latest 10-QQ3 FY2026MixedRestructuringImpairment / chargeLegal / investigation ·

    TREMFYA and oncology growth offset STELARA’s biosimilar erosion, but a proposed talc-settlement charge nearly wiped out earnings.

    • Revenue$25.4BYoY +5.9%
    • Net income$210.0MYoY −95.9%
  • PM Philip Morris International

    Exposed“PMI faces ongoing tobacco and nicotine litigation, including ZYN claims alleging addiction, misleading disclosures and marketing to minors;”

    Latest 10-QQ3 FY2026PositiveImpairment / charge ·

    Cigarette pricing and U.S. smoke-free growth lifted operating profit; ZYN’s packaging shift and added spending are expected to squeeze Q4 U.S. profitability.

    • Revenue$11.4BYoY +5.5%
    • Net income$3.3BYoY −4.7%
  • RRX Regal Rexnord

    Exposed“A subsidiary also faces numerous claims alleging fires involving sub-fractional motors manufactured primarily through 2004; although a liability is accrued, outcomes and potential remedial costs remain uncertain and could be significant.”

    Latest 10-QQ3 FY2026RestructuringImpairment / charge ·

    Planned autonomous mobile solutions sale triggers a goodwill write-down and quarterly loss despite data-center-led automation growth.

    • Revenue$1.6BYoY +6.1%
    • Net income−$12.5Mvs $79.6M year ago
  • RTX

    Exposed“The PW1100 GTF powder-metal condition continues to require accelerated inspections, removals, and retirements; RTX expects elevated A320neo aircraft-on-ground levels through 2026.”

    Latest 10-QQ3 FY2026PositiveImpairment / charge ·

    Tomahawk and AMRAAM awards drive missile-capacity expansion, while a customer bankruptcy weighs on Pratt & Whitney profitability.

    • Revenue$25.0BYoY +11.1%
    • Net income$2.6BYoY +34.7%
  • SWA Simwon America Corp.

    Exposed“Safety-critical components expose SIMWON to warranty, product-liability, and recall claims, including contribution claims related to automaker recalls.”

    Latest S-1/Aamended IPO prospectusCustomer concentrationControlled companyRelated-party dependence ·

    Makes automotive structural and chassis components; Tesla accounted for 99% of FY2026 revenue.

  • SYK Stryker Corporation

    Exposed“Stryker also faces product-liability, labor, tax, intellectual-property and other proceedings; it is self-insured for certain claims, and actual product-liability costs could materially exceed accruals.”

    Latest 8-KLeadership change ·

    Board expands to add Quest Diagnostics CEO James E. Davis, effective Jan. 1, 2027.

Feedback